Skip to content
iCHOR
HOME
TECHNOLOGY
iSWEEP PLATFORM TECHNOLOGY
iART ARTERIAL SYSTEM
iDVT VENOUS SYSTEM
ABOUT
WHY iCHOR?
NEWS & EVENTS
INVESTORS
PATIENTS
CASE STUDIES
iCHOR in the News
FAQs
iCHOR Frequently Asked Questions
iCHOR Business and Market FAQs
CONTACT US
LOGIN

Author: iCHOR

03Mar

Understanding the Benefits of Rep-Less Thrombectomy

What “Rep-Less” Thrombectomy Means In a traditional model, many thrombectomy procedures rely on having device reps in the room to guide product selection, setup, and...

Read more
20Feb

A No Compromise Approach to Peripheral Thrombectomy

Innovative new technologies like iSWEEP, embodied in iART and iDVT, clearly demonstrate that peripheral thrombectomy does not have to compromise. No longer do practitioners need...

Read more
17Feb

The Memo: iCHOR Vascular Simply Taking a Proven Surgical Fogarty Sweep Into the Endovascular Labs

Under the leadership of Co-Founder and CEO Tim Blair, ICHOR Vascular Inc. is advancing a new approach to treating peripheral vascular occlusions by converting one...

Read more

Posts pagination

Prev 1 … 4 5 6 … 10 Next

SEARCH

Search for:

ABOUT iCHOR

iCHOR was founded by Interventional Radiologist Dr. Troy Long and industry veteran Tim Blair.  They identified an opportunity to develop new technologies to address these large unmet needs in treating peripheral vascular occlusions. This collaboration has lead to the development of the iSWEEP platform technology that has converted the tried and true Fogarty balloon sweep technique from an open surgery to a simple, minimally-invasive endovascular procedure.

iCHOR

P.O. Box 810787, 
Boca Raton, FL 33481

info@ichorvascular.com

HOME
TECHNOLOGY
iSWEEP PLATFORM
iART ARTERIAL SYSTEM
iDVT VENOUS SYSTEM
ABOUT
NEWS & EVENTS
WHY iCHOR?
INVESTORS
PATIENTS
CONTACT US

TRANSLATE

iCHOR Vascular © 2025     |     Terms of Use     |      Privacy